Hesperetin Attenuates Experimentally Induced Skeletal Muscle Dysfunction by Modulating Time-of-Day-Dependent Gene Expression and Mitochondrial Redox-Related Markers.
Key claim: Hesperetin attenuates D-galactose- and dexamethasone-induced skeletal muscle dysfunction in myotubes and mice by partially restoring time-of-day-dependent clock and mitochondrial gene expression and improving mitochondrial redox and functional markers.
Abstract
Skeletal muscle aging is characterized by impaired myogenic differentiation, mitochondrial dysfunction, oxidative stress, and circadian rhythm disruption, contributing to sarcopenia and muscle atrophy. Hesperetin, a natural flavonoid, has antioxidant and mitochondrial protective effects; however, its role in skeletal muscle circadian regulation during aging remains unclear. This study investigated the effects of hesperetin (20 µM or 100 mg/kg b.w.) using D-galactose (D-gal, 20 g/L)-induced senescent C2C12 myotubes, a D-gal (150 mg/kg b.w., i.p.)-induced aging mouse model, and a dexamethasone (Dex, 20 mg/kg b.w., i.p.)-induced muscle atrophy model. In D-gal-treated mice, hesperetin improved hanging test performance and increased SDH-positive area, particularly during the active phase. Hesperetin also partially modulated core clock gene expression and mitochondrial function-related gene expression. In D-gal-induced senescent C2C12 myotubes, hesperetin improved myotube formation, reduced SA-β-gal-positive cells, DCF-DA fluorescence, and MDA levels, enhanced antioxidant enzyme activities, and improved mitochondrial-associated functional indicators, including ATP levels, mitochondrial membrane potential-related fluorescence,-based mitochondrial oxidation-associated signals, andexpression patterns. These findings suggest that hesperetin may protect against experimentally induced skeletal muscle dysfunction by modulating time-dependent gene expression, mitochondrial-related activities, and muscle-related functional markers.
Why this matters
Hesperetin attenuates D-galactose- and dexamethasone-induced skeletal muscle dysfunction in myotubes and mice by partially restoring time-of-day-dependent clock and mitochondrial gene expression and improving mitochondrial redox and functional markers.